ArticlePloS one2023

Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study protocol.

Anouk W M A Schaeffers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.